Clavister (CLAV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Nov, 2025Executive summary
Achieved record profitability with a 26% EBITDA margin, positive EBIT and net result, and a strong gross margin of 80%.
Net sales grew by 15% year-over-year in Q3 2025, with ARR up 9% and 16 consecutive quarters of growth.
Defence sector demand remains robust, highlighted by a 68 MSEK order from BAE Systems and a 98.5% year-over-year increase in defence net sales.
Expanded Arrow Electronics distribution agreement to 11 additional European countries, enhancing market reach.
Strong momentum in both civilian and defense sectors, with growing demand for European cybersecurity solutions.
Financial highlights
Q3 2025 net sales: 50.5 MSEK (up 15.3% year-over-year); gross profit: 41.0 MSEK (up 11.8%); adjusted EBITDA margin: 25.6%.
Order intake was SEK 31 million (31.4 MSEK), a 9% decline year-over-year due to timing effects in defense orders.
Net result for Q3: 0.3 MSEK, a turnaround from -5.1 MSEK in Q3 2024.
Cash position at quarter-end was SEK 40 million, with operations self-sustained at the operational level.
OpEx to sales ratio dropped to 72%, the lowest in company history, reflecting improved operating leverage.
Outlook and guidance
Full-year 2025 growth and EBIT targets withdrawn due to supply chain delays in military hardware, but underlying business remains robust.
Long-term ambition remains for industry-leading profitability and free cash flow; average annual sales growth target of at least 20% (CAGR) for 2025–2027.
New financial targets for 2026 and beyond will be set after fiscal year-end, once uncertainties subside.
EBITDA margin target range is 35%-40% in the medium term, balancing profitability and growth investments.
Latest events from Clavister
- Record order intake, strong defense wins, and improved financials drive future growth.CLAV
Q4 202512 Feb 2026 - Q2 net sales up 17% to 45M SEK, with strong order intake and positive cash flow.CLAV
Q2 202423 Jan 2026 - First positive EBIT, record margins, and strong order growth drive robust momentum.CLAV
Q3 202416 Jan 2026 - Double-digit growth, robust tech, and major defense contracts position for strong 2025 expansion.CLAV
ABGSC Investor Days12 Jan 2026 - Q4 net sales up 23% and ARR up 14.4%, with improved margins and strong order backlog.CLAV
Q4 202424 Dec 2025 - Order intake up 52%, net sales up 22%, and gross margin at 81.1% with major defence wins.CLAV
Q2 202523 Nov 2025 - Order intake up 190% and net sales up 21%, led by major defense and hardware contracts.CLAV
Q1 202522 Nov 2025